Ensysce Biosciences Inc (ENSC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.40
• Market Cap: $1.44M
• EPS: $-6.35
• 52-Week High: $5.72
• 52-Week Low: $0.31

Market Sentiment

Ensysce Biosciences Inc currently has a Neutral sentiment score of 0.13.

About Ensysce Biosciences Inc

Ensysce Biosciences Inc. is a clinical-stage biotechnology company headquartered in La Jolla, California, dedicated to pioneering transformative prescription drug solutions that tackle critical unmet medical needs. With a focus on innovative drug delivery technologies, Ensysce is actively developing pain management therapies aimed at mitigating the risks associated with opioid dependence. The company's commitment to pharmaceutical research and development underscores its potential to revoluti...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ensysce Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ENSC pay dividends?

Ensysce Biosciences Inc (ENSC) does not currently pay a regular dividend.

What is ENSC's market cap?

Ensysce Biosciences Inc (ENSC) has a market capitalization of $1.44M with a current stock price of $0.40.